Search Results 341-350 of 3628 for ❣[ 텔레 : ADSFIX01 ] 구글상단홍보 구글 SEO 상단노출❣
This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Investigator & Role, Grant Title, Funding Source, Duration. Nilufer Ertekin-Taner, M.D., Ph.D., site principal investigator, Centrally-linked longitudinal ...
About this study. The purpose of this study is to demonstrate 1) feasibility of digital biomarker assessment using wearable in children with solid tumors ...
Clinical worsening event is defined as 1 of the following: death, nonelective hospital admission of <24 hours due to worsening PAH or RHF, initiation of ...
Torgerson, Rochelle R. M.D., Ph.D. Associate Professor of Dermatology. Trabuco, Emanuel C. M.D. · trabuco.emanuel@mayo.edu; Associate Professor of ...
Links. Additional information is available from Mayo Clinic and government websites. For information about veteran's medical care, visit the VA Community ...
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide ...
The purpose of this study is to identify the magnitude of variation among intensivists in use of diagnostic testing and to determine whether variation in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.